S&P 500 7,724 +3.84% Nasdaq 26,363 +4.94% Dow Jones 54,349 +4.10% FTSE 100 10,921 +0.22% DAX 26,170 +2.18% Nikkei 225 65,683 +2.05% Hang Seng 25,497 -1.40% WTI Crude 75.20 -6.40% Gold 4,321 +7.12% US 10-Year Treasury Yield 4.617 -2.70% S&P 500 7,724 +3.84% Nasdaq 26,363 +4.94% Dow Jones 54,349 +4.10% FTSE 100 10,921 +0.22% DAX 26,170 +2.18% Nikkei 225 65,683 +2.05% Hang Seng 25,497 -1.40% WTI Crude 75.20 -6.40% Gold 4,321 +7.12% US 10-Year Treasury Yield 4.617 -2.70%

LATEST

Sebi releases consultation paper on separate rulebook for clearing corporations; seeks public comments till Aug 27●Datadog’s stock slides after earnings. This is what’s nagging at investors.●The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings●Bitcoin and ethereum prices today, Thursday, August 6, 2026: Prices firm as Hormuz negotiations continue and ADP jobs report misses●After nearly collapsing, Situational Awareness is betting $400 million on a private company●Nintendo beat earnings expectations even as Switch 2 hardware sales slumped●Greg Abel's Berkshire Hathaway May Have Repurchased Up to $11 Billion of Its Own Stock Last Quarter. Is This a Bullish Signal for Shareholders?●What Is Arc? The Stablecoin Blockchain From USDC Issuer Circle●Sebi releases consultation paper on separate rulebook for clearing corporations; seeks public comments till Aug 27●Datadog’s stock slides after earnings. This is what’s nagging at investors.●The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings●Bitcoin and ethereum prices today, Thursday, August 6, 2026: Prices firm as Hormuz negotiations continue and ADP jobs report misses●After nearly collapsing, Situational Awareness is betting $400 million on a private company●Nintendo beat earnings expectations even as Switch 2 hardware sales slumped●Greg Abel's Berkshire Hathaway May Have Repurchased Up to $11 Billion of Its Own Stock Last Quarter. Is This a Bullish Signal for Shareholders?●What Is Arc? The Stablecoin Blockchain From USDC Issuer Circle●

Front Page

Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company—finding its next blockbuster drug is proving difficult

fm-term-meta-233910339-mutual-fund | FORTUNE · 1h ago · 🇺🇸 United States

Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company—finding its next blockbuster drug is proving difficult

A clinical trial failure and U.S. competition have been tough for the Danish pharmaceutical firm. CFO Karsten Munk says the company is doubling down on innovation and its weight loss pills as it looks towards its next stage of growth.

Read the full story at fm-term-meta-233910339-mutual-fund | FORTUNE →

More Front Page

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

US Top News and Analysis · 9m ago

Bitcoin and ethereum prices today, Thursday, August 6, 2026: Prices firm as Hormuz negotiations continue and ADP jobs report misses

Yahoo Finance · 10m ago

Greg Abel's Berkshire Hathaway May Have Repurchased Up to $11 Billion of Its Own Stock Last Quarter. Is This a Bullish Signal for Shareholders?

Yahoo Finance · 20m ago

Nintendo Q1 2026 earnings beat estimates despite Switch 2 sales drop

Yahoo Finance · 22m ago